Literature DB >> 15023572

Chronic treatment with atypical neuroleptics induces striosomal FosB/DeltaFosB expression in rats.

Cristina Grande1, Hongwen Zhu, Ana B Martin, MoonSook Lee, Oscar Ortiz, Noboru Hiroi, Rosario Moratalla.   

Abstract

BACKGROUND: Studies have shown that neuroleptics regulate expression of the transcription factor FosB/DeltaFosB in the striatum, including the accumbens and caudate-putamen; however, the striatum is also divided into another structural dimension, the striosome and matrix compartments. The precise distribution of FosB/DeltaFosB induced by chronic neuroleptics in these striatal compartments is poorly understood.
METHODS: Rats received either single acute injections or chronic injections of clozapine (0 or 20 mg/kg, intraperitoneally [IP]), olanzapine (0 or 5 mg/kg, IP), or haloperidol (0 or 1.5 mg/kg, IP) for 25 days. The levels and compartmental distribution of FosB/DeltaFosB were examined.
RESULTS: Chronic clozapine induced clustered FosB/DeltaFosB expression within striosomes of the caudate-putamen. This pattern was due to increased levels of FosB/DeltaFosB in striosomes within the ventrolateral caudate-putamen and reduced levels of basal FosB/DeltaFosB in the matrix in the entire caudate-putamen. In contrast, chronic haloperidol increased FosB/DeltaFosB equally within the matrix and striosomes throughout the entire caudate-putamen. Chronic olanzapine induced an intermediate pattern.
CONCLUSIONS: The relative absence of FosB/DeltaFosB expression in the matrix correlates with the lack of parkinsonism of atypical neuroleptics. Expression of FosB/DeltaFosB in the matrix may contribute to parkinsonism of typical neuroleptics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023572     DOI: 10.1016/j.biopsych.2003.08.008

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

1.  Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems.

Authors:  M R Arnold; P H Williams; J A McArthur; A R Archuleta; C E O'Neill; J E Hassell; D G Smith; R K Bachtell; C A Lowry
Journal:  Neuropharmacology       Date:  2018-12-20       Impact factor: 5.250

2.  Parametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test-retest interval.

Authors:  Natashia Swalve; Ming Li
Journal:  Behav Pharmacol       Date:  2012-08       Impact factor: 2.293

Review 3.  A scale-free systems theory of motivation and addiction.

Authors:  R Andrew Chambers; Warren K Bickel; Marc N Potenza
Journal:  Neurosci Biobehav Rev       Date:  2007-05-03       Impact factor: 8.989

4.  Asenapine sensitization from adolescence to adulthood and its potential molecular basis.

Authors:  Qing Shu; Rongyin Qin; Yingzhu Chen; Gang Hu; Ming Li
Journal:  Behav Brain Res       Date:  2014-08-02       Impact factor: 3.332

Review 5.  Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules.

Authors:  William A Carlezon; Christine Konradi
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

6.  Haloperidol-induced striatal Nur77 expression in a non-human primate model of tardive dyskinesia.

Authors:  Souha Mahmoudi; Pierre J Blanchet; Daniel Lévesque
Journal:  Eur J Neurosci       Date:  2013-03-31       Impact factor: 3.386

7.  Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.

Authors:  Ainhoa Bilbao; Andrea Cippitelli; Ana Belén Martín; Noelia Granado; Oscar Ortiz; Erwan Bezard; Jiang-Fan Chen; Miguel Navarro; Fernando Rodríguez de Fonseca; R Moratalla
Journal:  Psychopharmacology (Berl)       Date:  2006-02-10       Impact factor: 4.530

8.  Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.

Authors:  Mario Gustavo Murer; Rosario Moratalla
Journal:  Front Neuroanat       Date:  2011-08-11       Impact factor: 3.856

9.  Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Authors:  Keon Sung Shin; Ting Ting Zhao; Keun Hong Park; Hyun Jin Park; Bang Yeon Hwang; Chong Kil Lee; Myung Koo Lee
Journal:  BMC Neurosci       Date:  2015-04-21       Impact factor: 3.288

10.  Effects of repeated voluntary or forced exercise on brainstem serotonergic systems in rats.

Authors:  M R Arnold; B N Greenwood; J A McArthur; P J Clark; M Fleshner; C A Lowry
Journal:  Behav Brain Res       Date:  2019-09-13       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.